CAS 95403-16-0

Formule : C17H16O5

InChI : InChI=1S/C17H16O5/c1-8-15(20)9(2)17-14(16(8)21)12(19)7-13(22-17)10-3-5-11(18)6-4-10/h3-6,13,18,20-21H,7H2,1-2H3

Code InChI : DYHOLQACRGJEHX-UHFFFAOYSA-N

SMILES : CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC=C(C=C3)O)C)O

Farrerol

CAS : 95403-16-0

Oxygen-heterocyclic compound

Formule : C₁₇H₁₆O₅

Degré de pureté : ≥ 95.0 % (HPLC)

Couleur et forme : Powder

Masse moléculaire : 300.31

Ref: 5G-82539

Farrerol

Produit contrôlé

CAS : 95403-16-0

Applications Farrerol is a modulator of ERK1/2 activity which regulates occludin expression in cells. This affects tight junctions in human cells which is related to various epidermal skin diseases and ailments.
References Lai-Cheong, J. et al.: J. Invest. Dermatol., 127, 2713 (2007); Li, J. et al.: Eur. J. Pharm., 734, 9 (2014);

Formule : C₁₇H₁₆O₅

Couleur et forme : Neat

Masse moléculaire : 300.31

Ref: TR-F101060

Farrerol

CAS : 95403-16-0

Farrerol is a natural compound that inhibits the angiotensin system and has been shown to have anti-inflammatory effects. It can be used for the treatment of inflammatory diseases, including arthritis, asthma, and psoriasis. Farrerol has also been shown to inhibit the production of collagenase in human serum, which may be due to its ability to suppress the activity of neutrophils. This molecule also has neuroprotective properties and can inhibit neuronal death after injury by inhibiting microglia activation. Farrerol is structurally similar to a polyketide synthase (PKS) intermediate and activates toll-like receptor 4 (TLR4) pathways.

Formule : C₁₇H₁₆O₅

Degré de pureté : Min. 95%

Masse moléculaire : 300.31 g/mol

Ref: 3D-VDA40316